 Cephodericol is a novel citrofocephalosporin that has been shown to be highly effective against multidrug-resistant gram-negative bacteria, including carbapenem-resistant strains. It has also been found to have a low resistance rate among enterobacterals, which highlights the importance of continued surveillance to prevent the emergence of resistance to this new drug. This article was authored by Mikayla Petovani, Anna Bertelli, Silvia Corballini, and others.